1. Home
  2. SLN vs TTSH Comparison

SLN vs TTSH Comparison

Compare SLN & TTSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLN
  • TTSH
  • Stock Information
  • Founded
  • SLN 1994
  • TTSH 1985
  • Country
  • SLN United Kingdom
  • TTSH United States
  • Employees
  • SLN N/A
  • TTSH N/A
  • Industry
  • SLN Biotechnology: Pharmaceutical Preparations
  • TTSH Blank Checks
  • Sector
  • SLN Health Care
  • TTSH Finance
  • Exchange
  • SLN Nasdaq
  • TTSH Nasdaq
  • Market Cap
  • SLN 352.2M
  • TTSH 295.2M
  • IPO Year
  • SLN N/A
  • TTSH N/A
  • Fundamental
  • Price
  • SLN $5.12
  • TTSH $7.03
  • Analyst Decision
  • SLN Strong Buy
  • TTSH
  • Analyst Count
  • SLN 4
  • TTSH 0
  • Target Price
  • SLN $61.50
  • TTSH N/A
  • AVG Volume (30 Days)
  • SLN 460.0K
  • TTSH 181.3K
  • Earning Date
  • SLN 03-11-2025
  • TTSH 02-27-2025
  • Dividend Yield
  • SLN N/A
  • TTSH N/A
  • EPS Growth
  • SLN N/A
  • TTSH N/A
  • EPS
  • SLN N/A
  • TTSH 0.08
  • Revenue
  • SLN $21,773,221.00
  • TTSH $352,075,000.00
  • Revenue This Year
  • SLN N/A
  • TTSH $8.17
  • Revenue Next Year
  • SLN $104.98
  • TTSH N/A
  • P/E Ratio
  • SLN N/A
  • TTSH $87.58
  • Revenue Growth
  • SLN N/A
  • TTSH N/A
  • 52 Week Low
  • SLN $4.82
  • TTSH $5.68
  • 52 Week High
  • SLN $27.72
  • TTSH $7.50
  • Technical
  • Relative Strength Index (RSI)
  • SLN 25.52
  • TTSH 59.19
  • Support Level
  • SLN $4.82
  • TTSH $6.49
  • Resistance Level
  • SLN $7.87
  • TTSH $7.14
  • Average True Range (ATR)
  • SLN 0.62
  • TTSH 0.23
  • MACD
  • SLN -0.01
  • TTSH 0.01
  • Stochastic Oscillator
  • SLN 9.20
  • TTSH 81.82

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risks of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.

About TTSH Tile Shop Holdings Inc.

Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States. It manufactures its setting and maintenance materials, such as thinset, grout, and sealers. The company's primary market is retail sales to consumers, contractors, designers, and home builders. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, metal and luxury vinyl tile.

Share on Social Networks: